Valiant Organics Limited · NSE:VALIANTORG
Valiant Organics — Q3 FY24 Earnings Presentation
24 slides from Valiant Organics's earnings presentation, Feb 14, 2024
Slide 1: Exchange filing cover letter: Investor Presentation
February 14, 2024 To, To, Listing/Compliance Department Listing/Compliance Department BSE LTD National Stock Exchange of Phiroze Jeejeebhoy Towers, India Limited Dalal Street, “Exchange Plaza”, Plot No. C/1, Mumbai- 400 001. G Block Bandra-Kurla Complex, Bandra (E), Mumbai- 400 051. SCRIP CODE - 540
Slide 2: Earnings Presentation | Q3/9M-FY24
Earnings Presentation | Q3/9M-FY24
Slide 3: Snapshot
SNAPSHOT One of the largest chlorophenol One of the leading manufacturer of derivatives manufacturer globally Benzene derivatives products One of the largest domestic PNA One of the few commercial players in manufacturer Ortho Anisidine and Para Anisidine Diversified client base across Amongst 1st f
Slide 4: Company Overview
Company Overview Valiant Organics Limited was incorporated in 1984 by first generation technocrats and is headquartered out of Mumbai, India. The company is focused on the manufacturing and marketing of specialty chemicals which find usage in a variety of industries, including agrochemicals, pharmac
Slide 5: Chemistries And Product Basket
Chemistries And Product Basket 9M-FY24 Revenue Share Hydrogenation Ammonolysis 42% Key Products: Industries Served: Key Products: Industries Served: • Ortho Anisidine • Dyes • Para Nitro Aniline • Para Anisidine • Dyes • Pigments • Ortho Chloro Para Nitro Aniline • Pigments • IPPCA • Pharmaceutical
Slide 6: Manufacturing Footprint
Manufacturing Footprint CHLORINATION – SARIGAM HYDROGENATION & METHOXYLATION- • Capacity: 18,000 MTPA JHAGADIA UNIT 1 • Products: PCP, OCP, 2,4 DCP, 2,6 DCP, • Capacity: 27,000 MTPA 2,4,6 TCP • Products: ONA/OA, PNA/PA, IPPCA, CONVERSION PRODUCTS AMMONOLYSIS - VAPI HYDROGENATION – JHAGADIA UNIT 2 •
Slide 7: Key Strengths
Key Strengths Domain expertise and broad Plant locations are process understanding in a Wide supply chain strategically located near variety of chemistries. The provides the continuous ports to provide a executive team is made up of availability of adequate competitive advantage, first-generation te
Slide 8: Q3/9M-FY24 Highlights
Q3/9M-FY24 HIGHLIGHTS Valiant Organics Limited | Q3-2024 7
Slide 9: Consolidated Financial Highlights
CONSOLIDATED FINANCIAL HIGHLIGHTS Q3-FY24 CONSOLIDATED FINANCIAL HIGHLIGHTS 9M-FY24 CONSOLIDATED FINANCIAL HIGHLIGHTS INR 1,414 Mn INR 5,463 Mn Operational Revenue Operational Revenue INR 38 Mn INR 432 Mn Operating EBITDA Operating EBITDA 2.69% 7.91% Operating EBITDA Margin Operating EBITDA Margin I
Slide 10: Q3/9M-FY24 Operational Highlights
Q3/9M-FY24 Operational Highlights Q3-FY24 Revenue Break-up – Chemistries • The overall performance for the quarter was under stress mainly from continued pressure on demand and pricing. Others, 7% • Prices for all the products have corrected significantly. On an overall basis, decline of 22% in the
Slide 11: Key Chemistries
Key Chemistries Chlorination (INR Mn) Hydrogenation (INR Mn) Ammonolysis (INR Mn) Others (INR Mn) 1, 200 1,076 545 500 136 600 160 600 501 1, 000 894 REVENUES 140 404 107 500 500 120 105 359 366 800 605 400 100 400 600 300 80 300 60 400 200 200 40 200 100 100 20 0 0 0 0 Q3-FY23 Q2-FY24 Q3-FY24 Q3-FY
Slide 12: Quarterly Consolidated Financial Performance
Quarterly Consolidated Financial Performance Particulars (INR Mn) Q3-FY24 Q3-FY23 Y-o-Y Q2-FY24 Q-o-Q Revenue from Operations 1,414 2,504 (43.5)% 2,031 (30.4)% Total Expenses 1,376 2,121 (35.1)% 1,876 (26.7)% EBITDA 38 383 (90.1)% 155 (75.5)% EBITDA Margins (%) 2.69% 15.30% NA 7.63% (494) Bps Other
Slide 13: YTD Consolidated Financial Performance
YTD Consolidated Financial Performance Particulars (INR Mn) 9M-FY24 9M-FY23 Y-o-Y Revenue from Operations 5,463 7,804 (30.0)% Total Expenses 5,031 6,684 (24.7)% EBITDA 432 1,120 (61.4)% EBITDA Margins (%) 7.91% 14.35% (644) Bps Other Income 72 52 38.5% Depreciation 262 212 23.6% Finance Cost 123 78
Slide 14: Quarterly Standalone Financial Performance
Quarterly Standalone Financial Performance Particulars (INR Mn) Q3-FY24 Q3-FY23 Y-o-Y Q2-FY24 Q-o-Q Revenue from Operations 1,414 2,176 (35.0)% 1,825 (22.5)% Total Expenses 1,376 1,892 (27.3)% 1,652 (16.7)% EBITDA 38 284 (86.6)% 173 (78.0)% EBITDA Margins (%) 2.69% 13.05% NA 9.48% (679) Bps Other In
Slide 15: YTD Standalone Financial Performance
YTD Standalone Financial Performance Particulars (INR Mn) 9M-FY24 9M-FY23 Y-o-Y Revenue from Operations 5,004 6,845 (26.9)% Total Expenses 4,591 5,986 (23.3)% EBITDA 413 859 (51.9)% EBITDA Margins (%) 8.25% 12.55% (430) Bps Other Income 9 23 (60.9)% Depreciation 252 201 25.4% Finance Cost 123 76 61.
Slide 16: Historical Financial Overview
HISTORICAL FINANCIAL OVERVIEW Valiant Organics Limited | Q3-2024 15
Slide 17: Historical Consolidated Income Statement
Historical Consolidated Income Statement Particulars (INR Mn) FY21 FY22 FY23 9M-FY24 Revenue from Operations 7,548 11,533 10,518 5,463 Total Expenses 5,496 9,484 8,875 5,031 EBITDA 2,052 2,049 1,643 432 EBITDA Margins (%) 27.19% 17.77% 15.62% 7.91% Other Income 59 74 80 72 Depreciation 212 296 292 2
Slide 18: Consolidated Balance Sheet
Consolidated Balance Sheet Particulars (INR Mn) FY22 FY23 H1-FY24 Particulars (INR Mn) FY22 FY23 H1-FY24 EQUITY 6,489 7,401 7,599 Non-Current Assets 6,652 7,682 8,132 a) Equity Share Capital 272 272 272 a) Property, Plant and Equipment 5,303 6,565 6,745 b) Other Equity 5,856 6,616 6,784 c) Right-Of-
Slide 19: Historical Standalone Income Statement
Historical Standalone Income Statement Particulars (INR Mn) FY21 FY22 FY23 9M-FY24 Revenue from Operations 5,742 9,484 9,116 5,004 Total Expenses 4,170 7,811 7,817 4,591 EBITDA 1,572 1,673 1,299 413 EBITDA Margins (%) 27.38% 17.64% 14.25% 8.25% Other Income 169 33 29 9 Depreciation 186 273 276 252 F
Slide 20: Standalone Balance Sheet
Standalone Balance Sheet Particulars (INR Mn) FY22 FY23 H1-FY24 Particulars (INR Mn) FY22 FY23 H1-FY24 EQUITY 6,031 6,661 6,804 Non-Current Assets 6,787 7,424 7,664 a) Equity Share Capital 272 272 272 a) Property, Plant and Equipment 5,085 6,092 6,255 b) Other Equity 5,755 6,385 6,528 b) Right-Of-Us
Slide 21: Consolidated Financial Highlights
Consolidated Financial Highlights Operational Revenue (INR Mn) EBITDA (INR Mn) & EBITDA Margins (%) PAT (INR Mn) & PAT Margins (%) 80.00% 1,309 1,279 2,052 1, 400 2,049 14, 000 11,533 2,100 70.00% 10,518 1,026 12, 000 1,800 1,643 1, 100 10, 000 60.00% 1,500 50.00% 8, 000 7,548 800 1,200 40.00% 5,463
Slide 22: Capital Market Information
Capital Market Information Share Price up to 31st December, 2023 30% 10% -10% -30% -50% -70% Jan-23 Feb-23 Mar-23 Apr-23 May-23 Jun-23 Jul-23 Aug-23 Sep-23 Oct-23 Nov-23 Dec-23 Valiant Organics Sensex Price Data (As on 31st December, 2023) INR Shareholding pattern (As on 31st December, FII, 0.69% DI
Slide 23: Disclaimer
Disclaimer Valiant Organics Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all event
Slide 24: Thank You
THANK YOU Valiant Organics Limited | Q3-2024 23